BSN

Aromavex

Serving
1 Capsule(s)
Per container
90
Form
capsule-unknown
UPC
834266004201
DSLD
Formula hash
778f4a25aa6a
Brand context
Catalog
224
products
With avoid flag
9
products
FDA recalls
0
history
CAERS
6
reports
Avoid-flaggedObjective label signals
Flagged excipients
5
1 avoid · 4 caution
FDA recalls
0
no recall history
CAERS reports
6
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

3 active ingredients
IngredientAmount% DV
Vitamin D
vitaminUNII · 9VU1KI44GP
UL · set4 effects
250 IU63%
Calcium
mineralUNII · SY7Q814VUP
UL · set6 effects
18 mg2%
AROMAVEX Interfusion
Proprietary Blend (Combination)other
720 mg
What this product supports · authorized claims

8 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

Flagged excipients

5 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

  • ◐ CAUTIONFD&C Red #3
    color

    FDA revoked food/ingested-drug color additive approval for FD&C Red 3 in January 2025 (Docket FDA-2022-C-2886). Manufacturers have until January 2027 (foods) / January 2028 (ingested drugs) to reformulate.

  • ◐ CAUTIONFD&C Yellow #6
    color

    EU requires 'attention in children' warning per Reg 1333/2008 Annex III (Southampton study 2007). Banned in Norway + Finland; allowed in US under 21 CFR 74.706 with declaration.

  • ◐ CAUTIONFD&C Red #40
    color

    EU requires the same 'attention/activity in children' warning label as Yellow 5 per Commission Regulation 1333/2008 Annex III. California enacted a public-school ban effective 2028 (AB 2316, 2024).

  • ◐ CAUTIONFD&C Blue #1
    color

    EU requires 'attention in children' warning per Commission Regulation 1333/2008 Annex III. Limited to specific food categories; capsule-shell use permitted with restrictions.

FDA CAERS · adverse event context
6
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Gelatin · Silicon Dioxide · Magnesium Stearate · Microcrystalline Cellulose